Embla Medical Company Description

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care.

The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints.

Its Bracing and Supports segment provides bracing and supports products, such as supporting devices for spinal, hip, knee, foot, ankle, and hands; and injury solutions for people recovering from fractures, need post-operative treatment, and ligament injuries.

The Patient Care segment offers prosthetics for people with lower and upper limb loss or limb difference; and orthotics for neurological, gait, and musculoskeletal conditions.

It serves specialized healthcare providers, such as orthopedic and prosthetic clinics, hospitals, and surgery centers.

It sells its products through its direct sales networks and distributors. The company was formerly known as Össur hf. and changed its name to Embla Medical hf. in April 2024.

Embla Medical hf. was incorporated in 1971 and is headquartered in Reykjavik, Iceland. Embla Medical hf. is a subsidiary of William Demant Invest A/S.

Embla Medical hf.

Country	Iceland
Founded	1971
Industry	Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Employees	4,061
CEO	Sveinn Solvason

Contact Details

Address: Grjótháls 5 Reykjavik Iceland
Website	emblamedical.com

Stock Details

Ticker Symbol	0FIW
Exchange	London Stock Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	3842

Key Executives

Name	Position
Sveinn Solvason	Chief Executive Officer
Gudny Sveinsdottir	Chief Financial Officer
Lukas Marklin	Chief Operating Officer
Klaus Sindahl	Head of Investor Relations